Infectious disease modelling

We translate preclinical data to human to inform first dose in human, the therapeutic dose and the therapeutic index.
By integrating time-to-kill, in vitro MIC concentrations and preclinical PK information a viral / bacterial kinetic model is established that can inform the PK/PD relationship in patients.